한국어
  1. Map
  2. Tokyo
  3. 渋谷きむらクリニック

渋谷きむらクリニック

Registry unverifiedTokyo

The clinic's site describes self-pay GLP-1 care. We could not find the same name and address in the MHLW open registry data (2026-06). It may be newly opened or registered under another name.

What we verified

Each item shows the source and the date we checked the clinic's official site. Items without evidence are marked 'Unverified'.

GLP-1 (Mounjaro) self-pay treatment
YesSource: shibuyakimuraclinic.com (new window) · Checked 2026-11-14
Accepts visitors
Unverified
Korean support
NoneSource: shibuyakimuraclinic.com (new window) · Checked 2026-11-14
Same-day visit
Unverified
Hotel delivery
Unverified
In-clinic pickup
Unverified
English prescription / letter
Unverified

Prices published by the clinic

Copied from the clinic's site. Consultation and delivery fees may be extra; prices change.

ItemJPYTaxChecked
マンジャロ 2.5mg 2本(半月)¥6,600incl.2026-11-14 · Source (new window)
マンジャロ 2.5mg 4本(1ヶ月)¥9,900incl.2026-11-14 · Source (new window)
マンジャロ 5mg 4本¥19,800incl.2026-11-14 · Source (new window)
マンジャロ 7.5mg 4本¥29,700incl.2026-11-14 · Source (new window)
マンジャロ 10mg 4本¥39,600incl.2026-11-14 · Source (new window)
マンジャロ 12.5mg 4本¥49,700incl.2026-11-14 · Source (new window)
マンジャロ 15mg 4本¥59,600incl.2026-11-14 · Source (new window)

Risks to know

GLP-1 injections commonly cause nausea, vomiting, diarrhea and constipation; rare reports include acute pancreatitis, hypoglycemia and vision problems (NAION). In Japan, Mounjaro is approved for type 2 diabetes only; weight-management use is off-label. Medicines prescribed abroad do not appear in Korea's DUR records and are hard to cover under its adverse-reaction relief scheme.

SushiMedi does not advertise clinics or medicines and does not refer patients. Treatment decisions are made by the local doctor. Medicines prescribed abroad are not covered by Korea's adverse-reaction relief scheme. Follow MFDS and Korea Customs rules when bringing medicines home.